Shmon-FX Oral Suspension Orange

Shmon-FX Oral Suspension Orange is a combination medicine used in the treatment of allergy symptoms such as runny nose, stuffy nose, sneezing, watery eyes, and congestion or stuffiness.

Shmon-FX Oral Suspension Orange is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect, or be affected by this medicine.

The most common side effects are nausea, diarrhea, vomiting, skin rash, flu- like symptoms, and headache. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. This medicine may cause dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid drinking alcohol while taking this medicine as it can worsen your sleepiness.

Never support self-medication or recommend your medicine to another person. It is beneficial to have plenty of fluids while taking this medication. Before you start taking this medicine it is important to inform your doctor if you are suffering from liver or kidney disease. You should also tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

• Treatment of Sneezing and runny nose due to allergies

Treatment of Sneezing and runny nose due to allergies
Shmon-FX Oral Suspension Orange is a combination medicine that provides relief from symptoms such as blocked or runny nose, sneezing and itchy or watery eyes. This will make it easier for you to go about your daily activities. It rarely has any serious side effects and you may only need to take it on days you have symptoms. If you are taking it to prevent getting symptoms you should use it regularly to get the most benefit.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Monten FX

• Nausea
• Diarrhea
• Vomiting
• Skin rash
• Flu-like symptoms
• Headache
• Drowsiness
• Dizziness

Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Shmon-FX Oral Suspension Orange may be taken with or without food, but it is better to take it at a fixed time.

Montelukast is a leukotriene antagonist. It works by blocking the action of a chemical messenger called leukotriene. This reduces inflammation (swelling) in the airways and nose and improves symptoms. Fexofenadine is an antiallergic which blocks the action of another chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing.

• You have been prescribed Shmon-FX Oral Suspension Orange to help relieve symptoms of allergy such as runny nose, sneezing, watery eyes, and cough.
• Be cautious while driving or doing anything that requires concentration as Shmon-FX Oral Suspension Orange can cause dizziness and sleepiness.
• Do not drink alcohol while taking Shmon-FX Oral Suspension Orange as it may cause increased sleepiness.
• Stop taking Shmon-FX Oral Suspension Orange at least three days before taking an allergy test as it can affect the test results.

Montelukast sodium. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012 [revised 04 Jan. 2018]. [Accessed 19 Apr. 2019] (online) Available from:

Drugs.com. Fexofenadine. [Accessed 01 Apr. 2019] (online) Available from:

Montelukast sodium. Whitehouse Station, New Jersey: Merck & Co., Inc.; 1998 [revised Nov. 2014]. [Accessed 19 Apr. 2019] (online) Available from:

Fexofenadine hydrochloride. Beverley: Dr. Reddy's Laboratories (UK) Ltd.; 2008 [revised 13 Sep. 2018]. [Accessed 19 Apr. 2019] (online) Available from: